1. Teece, D. J. (1986). Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy. Research Policy.

  2. Gans, J. S., & Stern, S. (2003). The product market and the market for “ideas”: commercialization strategies for technology entrepreneurs. Research Policy.

  3. Oostrom, T. (2024). Funding of Clinical Trials and Reported Drug Efficacy. Journal of Political Economy.

  4. Kao, J. (2025). Information Disclosure and Competitive Dynamics: Evidence from the Pharmaceutical Industry. Management Science.

  5. Roche, M. P., Oettl, A., & Catalini, C. (2024). Proximate (Co-)Working: Knowledge Spillovers and Social Interactions. Management Science.

  6. Roche, M. P. (2020). Taking Innovation to the Streets: Microgeography, Physical Structure, and Innovation. The Review of Economics and Statistics.

  7. Budish, E., Roin, B. N., & Williams, H. (2015). Do Firms Underinvest in Long-Term Research? Evidence from Cancer Clinical Trials. American Economic Review.

  8. Banerjee, S., & Lin, P. (2003). Downstream R&D, raising rivals’ costs, and input price contracts. International Journal of Industrial Organization.

  9. Krieger, J. L. (2021). Trials and Terminations: Learning from Competitors’ R&D Failures. Management Science.

  10. Catalini, C. (2018). Microgeography and the Direction of Inventive Activity. Management Science.